Aindro Pharmaceuticals Private Limited
About Aindro Pharmaceuticals Private Limited
Data last updated:
Aindro Pharmaceuticals Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2001.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2001PTC047374. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹16.55 Cr and a paid-up capital of ₹2.93 Cr. It was led by directors Sudhakar Natarajan and Bhuvana.
Its last annual general meeting (AGM) was held on 28 May 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Plot No.6 Park View Apartments Nagendra Nagar Velachery, Chennai, Tamil Nadu, India – 600042.
As per the financials filed for FY 2019, the company reported a revenue of ₹63.61 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹72.96 Lakh (net margin -114.7%) and EBITDA of ₹28.56 Lakh (EBITDA margin 44.9%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years.
As per MCA filings, the company had satisfied charges of ₹37.15 Cr on record.
Company details
Contact details
Aindro Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.6 Park View Apartments Nagendra Nagar Velachery, Chennai, Tamil Nadu, India – 600042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aindro Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aindro Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aindro Pharmaceuticals Private Limited, buy the company report.
Financials of Aindro Pharmaceuticals Private Limited
FY 2019 filings availableAindro Pharmaceuticals Private Limited reported revenue of ₹63.61 Lakh (down 39% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over three years, including a 39% fall in the latest year. EBITDA fell 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹72.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.9% | ||||
| Net Profit Margin | -114.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aindro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aindro Pharmaceuticals Private Limited
Aindro Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhakar Natarajan Also directs: Aindro Estates Private Limited, Colors Condominium Private Limited | Director | 04 Jul 2001 | 25 Years 3 Months | As last reported |
| Bhuvana Also directs: Aindro Estates Private Limited, Colors Condominium Private Limited | Director | 02 Jan 2003 | 23 Years 9 Months | As last reported |
Auditor
Aindro Pharmaceuticals Private Limited is audited by AR ANNAMALAI & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AR ANNAMALAI & CO | FY 2016 | 000207S |
Shareholding
The shareholding of Aindro Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aindro Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2007 | 10110774 | State Bank of India | ₹27.25 Cr | Satisfied | |
| 31 Jul 2004 | 90290465 | Union Bank of India | ₹9.9 Cr | Satisfied |
To see the full charge records of Aindro Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Aindro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aindro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aindro Pharmaceuticals has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aindro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aindro Pharmaceuticals Private Limited has 6 board changes on record since 2001: 2 appointments and 4 cessations. The latest: Nagarajan Pramodh ceased to be Director on 11 Feb 2019.
3 earlier events are in the company report.
Frequently asked questions
Aindro Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Aindro Pharmaceuticals was a private limited company based in Chennai, Tamil Nadu, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2001 and is registered under CIN U24231TN2001PTC047374. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Aindro Pharmaceuticals was incorporated on 04 July 2001. It is registered with the Registrar of Companies, Chennai.
Aindro Pharmaceuticals had 2 directors:
- Sudhakar Natarajan - Director
- Bhuvana - Director
The CIN (Corporate Identification Number) of Aindro Pharmaceuticals is U24231TN2001PTC047374. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aindro Pharmaceuticals is at Plot No.6 Park View Apartments Nagendra Nagar Velachery, Chennai, Tamil Nadu, India – 600042.
The latest financial statements of Aindro Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 28 May 2019. Year-wise statements from 2015 are in the company report.
No. Aindro Pharmaceuticals has 3 GST registrations on record and all of them are cancelled or inactive.
Aindro Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
Nagarajan Pramodh ceased to be Director on 11 Feb 2019. Thulasi Venkataramanan Brinda ceased to be Director on 11 Feb 2019. Bernice Sugirtha ceased to be Director on 02 Nov 2009. Aindro Pharmaceuticals has 6 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
